References
- Wuchter PP, Ran D, Bruckner T, . Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation. Biol Blood Marrow Transplant 2010;16:490–499.
- Sharp JG, McGuire TR, Mann SL, . Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization. Cytotherapy 2002;4:365–373.
- Roberts AW, Foote S, Alexander WS, . Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 1997;89:2736–2744.
- Morris CL, Siegel E, Barlogie B, . Mobilization of CD34 + cells in elderly patients (>/ = 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003;120:413–423.
- Hosing C, Saliba RM, Ahlawat S, . Stem cell mobilization in multiple myeloma patients: do we need an age-adjusted regimen for the elderly?Am J Hematol 2009;84:335–337.
- Blaise D, Farnault L, Faucher C, . Reduced-intensity conditioning with fludarabin, oral busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies. Exp Hematol 2010;38: 1241–1250.
- Crocchiolo R, Fürst S, Esterni B, . Two days of ATG in the conditioning regimen is associated with a reduced incidence of both acute and chronic GvHD without increasing relapse in RIC transplant for haematological diseases. Bone Marrow Transplant 2011;46(Suppl. 1s): Abstract 288.
- Lemarie C, Bouchet G, Sielleur I, . A new single-platform method for the enumeration of CD34 + cells. Cytotherapy 2009;11:804–806.
- Gordan LN, Sugrue MW, Lynch JW, . Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2003;44:815–820.
- Goterris R, Hernández-Boluda JC, Teruel A, . Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005;36:847–853.